LifeMD, Inc. - Common Stock (LFMD)
6.3650
+0.0450 (0.71%)
Lifemd Inc is a biotechnology company focused on advancing personalized medicine by leveraging cutting-edge technology and data analytics to develop innovative diagnostic solutions and therapeutics
Their mission centers around improving patient outcomes through tailored healthcare approaches, harnessing the power of genetic information and biomarkers to better understand individual health traits and disease predispositions. By aiming to provide precise treatment options, Lifemd Inc is dedicated to transforming the landscape of healthcare and empowering patients with actionable insights for managing their health.
![](https://investorplace.com/wp-content/uploads/2020/09/telehealth_1600_b.jpg)
Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement.
Via InvestorPlace · July 16, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 10, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/09/xrdDAFqZwXnoXk2-j7421204755476627396-t23.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · May 9, 2024
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 19, 2024
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 18, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/09/Wall-Street-US-stocks.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · May 9, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
LFMD stock results show that LifeMD beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
Via Investor's Business Daily · April 30, 2024
![](https://www.investors.com/wp-content/uploads/2023/04/Stock-Dexcom-03-company.jpeg)
Dexcom earns a lofty No. 5 rank among its peers in the 130-stock Medical-Products industry group. It got a rating upgrade Tuesday.
Via Investor's Business Daily · April 30, 2024
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
Via Investor's Business Daily · April 25, 2024
![](https://www.investors.com/wp-content/uploads/2020/06/Stock-Diabetes-01-adobe.jpg)
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
Via Investor's Business Daily · March 26, 2024
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
Via Investor's Business Daily · March 19, 2024
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.
Via Investor's Business Daily · March 18, 2024
![](https://investorplace.com/wp-content/uploads/2020/09/telehealth_1600_b.jpg)
With growing demand, the market for telemedicine stocks could be worth about $450 billion by the time 2032 rolls around.
Via InvestorPlace · March 14, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · March 11, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Ballard Power Systems (NASDAQBLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
Via Benzinga · March 11, 2024
![](https://investorplace.com/wp-content/uploads/2021/05/bank-lending-capital-1600.jpg)
These three companies are beaten up stocks to buy, as their oversold status and solid fundamentals make them attractive picks.
Via InvestorPlace · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/01/04/image39.jpeg?width=1200&height=800&fit=crop)
Shares of Mobileye Global Inc. (NASDAQMBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Via Benzinga · January 4, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 4, 2024
![](https://investorplace.com/wp-content/uploads/2019/07/small-cap-picks.jpg)
The market rally is showing signs of broadening to include small-cap stocks, here are seven that analysts are upgrading
Via InvestorPlace · December 22, 2023
![](https://cdn.benzinga.com/files/images/story/2023/12/13/med.png?width=1200&height=800&fit=crop)
Virtual primary care services provider LifeMD Inc (NASDAQLFMD) announced a strategic alliance with Medifast Inc NYSE: MEDNYSEMED)
Via Benzinga · December 13, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 13, 2023